FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898165004> ?p ?o ?g. }

• W2898165004 endingPage "353" @default.
• W2898165004 startingPage "350" @default.
• W2898165004 abstract "Purpose: To test the hypothesis that the US Food and Drug Administration approval of vismodegib in early 2012 has reduced the prevalence of orbital exenteration for locally advanced periocular basal cell carcinoma (BCC). Methods: Following institutional review board approval, the authors reviewed clinical and pathological data of patients with locally advanced periocular BCC (T4 per the eyelid carcinoma classification in the 8th edition of the AJCC Cancer Staging Manual ) treated by the senior author during 2006–2018. Patients were grouped into those who were treated before February 2012 (“before vismodegib approval”) and those who presented later (“after vismodegib approval”). Results: Forty-two patients with locally advanced periocular BCC were treated during the study period, of whom 31 were men. The median age at presentation was 66 years (range, 43–90). Twenty-two patients had T4a and 20 had T4b tumors. Thirteen patients were treated before and 29 were treated after vismodegib approval. The 2 groups did not differ in age distribution ( p = 0.164), sex distribution ( p = 0.270), prevalence of recurrent tumor at presentation ( p = 0.317), or duration of treatment with vismodegib ( p = 0.605). Orbital exenteration was significantly more prevalent in patients treated before vismodegib approval than after (46% vs. 10%, p = 0.016), and vismodegib treatment was significantly more prevalent in patients treated after vismodegib approval than before (when vismodegib was given in clinical trials; 69% vs. 23%, p = 0.008). There was a trend toward more patients retaining their eyes at last follow-up in patients treated after vismodegib approval (83% vs. 54%, p = 0.066). Conclusions: The prevalence of orbital exenteration as a necessary surgical procedure in patients with a locally advanced periocular BCC has fallen since the Food and Drug Administration approval of vismodegib. Although vismodegib is not specifically approved for organ-sparing, it has changed the authors’ practice and enabled eye preservation in patients with locally advanced periocular BCC, who would otherwise require an orbital exenteration." @default.
• W2898165004 created "2018-11-02" @default.
• W2898165004 creator A5007020035 @default.
• W2898165004 creator A5024203346 @default.
• W2898165004 creator A5039103793 @default.
• W2898165004 creator A5063476112 @default.
• W2898165004 creator A5072939839 @default.
• W2898165004 creator A5073466449 @default.
• W2898165004 creator A5076491232 @default.
• W2898165004 creator A5085259404 @default.
• W2898165004 creator A5087888952 @default.
• W2898165004 creator A5091775851 @default.
• W2898165004 date "2019-07-01" @default.
• W2898165004 modified "2023-10-17" @default.
• W2898165004 title "Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma" @default.
• W2898165004 cites W1977078600 @default.
• W2898165004 cites W2008976442 @default.
• W2898165004 cites W2011359750 @default.
• W2898165004 cites W2034848002 @default.
• W2898165004 cites W2067466738 @default.
• W2898165004 cites W2137271428 @default.
• W2898165004 cites W2170611398 @default.
• W2898165004 cites W2421636635 @default.
• W2898165004 cites W2588244614 @default.
• W2898165004 cites W2739608332 @default.
• W2898165004 cites W2805647977 @default.
• W2898165004 doi "https://doi.org/10.1097/iop.0000000000001251" @default.
• W2898165004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30365473" @default.
• W2898165004 hasPublicationYear "2019" @default.
• W2898165004 type Work @default.
• W2898165004 sameAs 2898165004 @default.
• W2898165004 citedByCount "19" @default.
• W2898165004 countsByYear W28981650042019 @default.
• W2898165004 countsByYear W28981650042020 @default.
• W2898165004 countsByYear W28981650042021 @default.
• W2898165004 countsByYear W28981650042022 @default.
• W2898165004 countsByYear W28981650042023 @default.
• W2898165004 crossrefType "journal-article" @default.
• W2898165004 hasAuthorship W2898165004A5007020035 @default.
• W2898165004 hasAuthorship W2898165004A5024203346 @default.
• W2898165004 hasAuthorship W2898165004A5039103793 @default.
• W2898165004 hasAuthorship W2898165004A5063476112 @default.
• W2898165004 hasAuthorship W2898165004A5072939839 @default.
• W2898165004 hasAuthorship W2898165004A5073466449 @default.
• W2898165004 hasAuthorship W2898165004A5076491232 @default.
• W2898165004 hasAuthorship W2898165004A5085259404 @default.
• W2898165004 hasAuthorship W2898165004A5087888952 @default.
• W2898165004 hasAuthorship W2898165004A5091775851 @default.
• W2898165004 hasConcept C126322002 @default.
• W2898165004 hasConcept C141071460 @default.
• W2898165004 hasConcept C143998085 @default.
• W2898165004 hasConcept C2778804307 @default.
• W2898165004 hasConcept C2779545874 @default.
• W2898165004 hasConcept C3019992690 @default.
• W2898165004 hasConcept C71924100 @default.
• W2898165004 hasConceptScore W2898165004C126322002 @default.
• W2898165004 hasConceptScore W2898165004C141071460 @default.
• W2898165004 hasConceptScore W2898165004C143998085 @default.
• W2898165004 hasConceptScore W2898165004C2778804307 @default.
• W2898165004 hasConceptScore W2898165004C2779545874 @default.
• W2898165004 hasConceptScore W2898165004C3019992690 @default.
• W2898165004 hasConceptScore W2898165004C71924100 @default.
• W2898165004 hasIssue "4" @default.
• W2898165004 hasLocation W28981650041 @default.
• W2898165004 hasLocation W28981650042 @default.
• W2898165004 hasOpenAccess W2898165004 @default.
• W2898165004 hasPrimaryLocation W28981650041 @default.
• W2898165004 hasRelatedWork W1803222855 @default.
• W2898165004 hasRelatedWork W2071250613 @default.
• W2898165004 hasRelatedWork W2153743952 @default.
• W2898165004 hasRelatedWork W2607360241 @default.
• W2898165004 hasRelatedWork W2901949882 @default.
• W2898165004 hasRelatedWork W3045377858 @default.
• W2898165004 hasRelatedWork W3126292731 @default.
• W2898165004 hasRelatedWork W3196037314 @default.
• W2898165004 hasRelatedWork W4304804698 @default.
• W2898165004 hasRelatedWork W1920413731 @default.
• W2898165004 hasVolume "35" @default.
• W2898165004 isParatext "false" @default.
• W2898165004 isRetracted "false" @default.
• W2898165004 magId "2898165004" @default.
• W2898165004 workType "article" @default.